1991
DOI: 10.1172/jci115154
|View full text |Cite
|
Sign up to set email alerts
|

Reversal of daunorubicin resistance in P388/ADR cells by itraconazole.

Abstract: Itraconazole is a recently developed triazole antifungal agent that inhibits cell membrane sterol biosynthesis. Itraconazole, in a dose-dependent manner, enhanced intracellular accumulation of daunorubicin and reversed the drug resistance in murine leukemia P388/ADR cells. In addition, itraconazole corrected the altered plasma membrane potentials of P388/ADR cells. The concentrations of itraconazole that reversed drug resistance are comparable to the plasma levels achieved by therapeutic dosage used in the tre… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
31
0

Year Published

1995
1995
2017
2017

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 51 publications
(31 citation statements)
references
References 18 publications
0
31
0
Order By: Relevance
“…Because MDR3/ABCB4 has the closest similarity to MDR1/ABCB1 among genes in the ABC transporter family and is known to have some overlapping substrate specificities with MDR1, such as digoxin, paclitaxel, and vinblastine (Smith et al, 2000), cholestatic drugs that can act as MDR1 inhibitors may also inhibit MDR3-mediated biliary secretion of phospholipids. In fact, ITZ is a potential inhibitor of MDR1 (Gupta et al, 1991;Takara et al, 1999;Iida et al, 2001) and MDR3. Furthermore, tacrine, which often increases LFTs, may also have an inhibitory effect on MDR3; its risk of hepatotoxicity was particularly high in humans carrying some variants of the MDR3 gene (Alfirevic et al, 2007).…”
Section: Discussionmentioning
confidence: 99%
“…Because MDR3/ABCB4 has the closest similarity to MDR1/ABCB1 among genes in the ABC transporter family and is known to have some overlapping substrate specificities with MDR1, such as digoxin, paclitaxel, and vinblastine (Smith et al, 2000), cholestatic drugs that can act as MDR1 inhibitors may also inhibit MDR3-mediated biliary secretion of phospholipids. In fact, ITZ is a potential inhibitor of MDR1 (Gupta et al, 1991;Takara et al, 1999;Iida et al, 2001) and MDR3. Furthermore, tacrine, which often increases LFTs, may also have an inhibitory effect on MDR3; its risk of hepatotoxicity was particularly high in humans carrying some variants of the MDR3 gene (Alfirevic et al, 2007).…”
Section: Discussionmentioning
confidence: 99%
“…Itraconazole can also reverse resistance to the P-gp substrate daunorubicin (DNR) in a murine acute leukemia cell line in vitro (multidrug-resistant cells) (13), while the methylthiazolyl diphenyltetrazolium bromide (MTT) cytotoxicity assay results suggest an interaction of itraconazole with MDR and/or multidrug resistance protein (MRP)-associated resistance because of resistance reversal (18). The transport of vinblastine, DNR, and doxorubicin is affected by 100 M itraconazole in cells transfected with MDR1 cDNA (31).…”
mentioning
confidence: 99%
“…The transport of vinblastine, DNR, and doxorubicin is affected by 100 M itraconazole in cells transfected with MDR1 cDNA (31). Furthermore, clinical interactions have been reported following coadministration of itraconazole with vincristine (2), DNR (13,33), quinidine (16), or digoxin (15), all of which, it has been asserted, are P-gp substrates (with the first three being well characterized). Lovastatin concentrations increased more than 20-fold when it was coadministered with itraconazole (22).…”
mentioning
confidence: 99%
“…22) Reversal of resistance has also been reported for itraconazole, where daunorubicin and adriamycin resistance was reversed at a concentration of 1-2.5 mg/ml in P388/ADR 23) and K562/ADR, 24) respectively. The data on the interactions of antifungal drugs with MDR1 varied depending on the experimental system, and no a) The values are the meansϮS.D.…”
Section: )mentioning
confidence: 73%